Rapiscan 400 µg/ 5 ml, Injektionslösung
7680661370013
CH-66137
Injektionslösung
Associated product:
RAPISCAN sol inj 400 mcg/5ml flac 5 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
regadenosonum
|
400.0 UG | Substance | Wirkstoff (Principe actif) |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas
|
- | Substance | HNIDK |
|
propylenglycolum
|
750.0 MG | Substance | HBESI |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
19.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 114.60
Specialties list
Yes
Generic
No
SL addition date:
01/02/2018
Authorization holder
GE Healthcare AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 66137
- Drug name
- Rapiscan, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- C01EB21
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 28/07/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 14.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- RAPISCAN sol inj 400 mcg/5ml flac 5 ml
- Description (DE)
- RAPISCAN Inj Lös 400 mcg/5ml Durchstf 5 ml
- Market launch
- 28/07/2017
- Narcotic (BTM)
- No